Product Description
Mechanisms of Action: No Mechanism
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral,Topical
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: Argentina | Austria | Belgium | Colombia | Dominican Republic | Ecuador | Finland | Germany | Hungary | Italy | Mexico | Peru | Portugal | Slovenia | United Arab Emirates
Approved Indications: None
Known Adverse Events: None
Company: Colgate Palmolive
Company Location: NEW YORK NY 10022
Company CEO: Noel R. Wallace
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Phase 4: Gingivitis|Inflammation
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
---|---|---|---|---|---|
GASAS-1007X | P4 |
Completed |
Gingivitis|Inflammation |
2012-01-01 |